China BlueChemical Ltd Class H (HK:3983)
:3983
Want to see HK:3983 full AI Analyst Report?
Top Page
China BlueChemical
(3983)
Select Model
Select Model
Rating:63Neutral
Price Target:
HK$2.50
â–²(0.00% Upside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by solid financial stability (low leverage) and positive free cash flow, offset by a clear deterioration in recent revenue/margins. Technical indicators add near-term caution, while the moderate P/E and strong dividend yield modestly improve the overall view.
Positive Factors
Conservative balance sheet
Low leverage and a large equity base provide durable financial flexibility for cyclical downturns. This capital structure cushions earnings volatility typical in fertilizers, supports continued investment or dividends, and reduces refinancing risk across a 2–6 month horizon and beyond.
Negative Factors
Sharp revenue decline and margin pressure
A large recent revenue drop and margin compression indicate reduced pricing power or volume loss. Such deterioration raises medium-term visibility risk, strains operating leverage, and can persist across seasons, undermining margin sustainability and forecasting reliability.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and a large equity base provide durable financial flexibility for cyclical downturns. This capital structure cushions earnings volatility typical in fertilizers, supports continued investment or dividends, and reduces refinancing risk across a 2–6 month horizon and beyond.
Read all positive factors
China BlueChemical (3983) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$10.74B
Dividend Yield5.44%
Average Volume (3M)5.27M
Price to Earnings (P/E)9.4
Beta (1Y)0.57
Revenue Growth0.79%
EPS Growth-9.29%
CountryHK
Employees3,653
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)0.21
Shares Outstanding1,796,000,100
10 Day Avg. Volume5,961,174
30 Day Avg. Volume5,270,130
Financial Highlights & Ratios
PEG Ratio-1.18
Price to Book (P/B)0.53
Price to Sales (P/S)0.83
P/FCF Ratio10.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.58Price Target Upside43.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.31
Revenue Forecast (FY)HK$13.05B
China BlueChemical Business Overview & Revenue Model
Company Description
China BlueChemical Ltd., together with its subsidiaries, develops, manufactures, and sells mineral fertilizers and chemical products in the People's Republic of China and internationally. The company operates through Urea, Phosphorus and Compound ...
How the Company Makes Money
China BlueChemical primarily makes money by producing and selling fertilizers and related chemical products. Its key revenue streams typically include: (1) Nitrogen fertilizer sales (e.g., urea and other nitrogen-based fertilizers), where revenue ...
China BlueChemical Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
78
Positive
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.03B | 11.95B | 12.99B | 14.28B | 13.40B |
| Gross Profit | 1.57B | 1.70B | 2.06B | 2.54B | 2.94B |
| EBITDA | 1.29B | 1.55B | 3.33B | 2.35B | 2.76B |
| Net Income | 974.44M | 1.07B | 2.38B | 1.64B | 1.50B |
Balance Sheet | |||||
| Total Assets | 24.85B | 24.08B | 24.32B | 23.50B | 21.43B |
| Cash, Cash Equivalents and Short-Term Investments | 14.04B | 13.51B | 13.74B | 12.55B | 11.23B |
| Total Debt | 2.11B | 2.12B | 2.02B | 2.08B | 1.05B |
| Total Liabilities | 4.87B | 4.57B | 4.91B | 5.72B | 4.52B |
| Stockholders Equity | 18.84B | 18.41B | 18.30B | 16.75B | 15.83B |
Cash Flow | |||||
| Free Cash Flow | 965.97M | 918.02M | 800.48M | 806.70M | 1.88B |
| Operating Cash Flow | 1.38B | 1.52B | 1.54B | 2.14B | 2.94B |
| Investing Cash Flow | -570.50M | -379.00M | -691.13M | -2.35B | -3.66B |
| Financing Cash Flow | -751.44M | -1.06B | -784.06M | 56.35M | -1.37B |
China BlueChemical Technical Analysis
Negative
2.50
Price Trends
2.71
Negative
2.73
Negative
2.57
Negative
Market Momentum
-0.11
Positive
23.77
Positive
7.18
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3983, the sentiment is Negative. The current price of 2.5 is below the 20-day moving average (MA) of 2.57, below the 50-day MA of 2.71, and below the 200-day MA of 2.57, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 23.77 is Positive, neither overbought nor oversold. The STOCH value of 7.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3983.
China BlueChemical Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$10.61B | 7.46 | 11.29% | 3.66% | 9.16% | 17.90% | |
63 Neutral | HK$10.74B | 9.39 | 5.22% | 5.44% | 0.79% | -9.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$12.83B | 11.71 | 9.60% | 3.23% | 9.64% | -37.53% | |
49 Neutral | HK$4.10B | 8.28 | 7.70% | ― | -5.68% | -25.13% | |
42 Neutral | HK$11.36B | 172.08 | 0.46% | 1.16% | -17.38% | 224.44% |
* Basic Materials Sector Average
HK:3983
China BlueChemical
2.30
0.43
22.99%
HK:0297
Sinofert Holdings
1.55
0.35
28.84%
HK:1866
China XLX Fertiliser Ltd.
10.12
5.83
135.90%
HK:0509
Century Sunshine Group Holdings Limited
0.17
0.00
0.00%
HK:1907
China Risun Group Ltd.
2.52
0.06
2.31%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
3.38
1.65
95.72%
China BlueChemical Corporate Events
China BlueChemical Shareholders Approve All AGM Resolutions and Capital Mandates
May 28, 2026
China BlueChemical reported that all resolutions proposed at its 2025 annual general meeting, as well as at separate class meetings for H shareholders and domestic shareholders, were duly passed. Shareholder participation was strong, with about 76...
China BlueChemical Sets Final 2025 Dividend and Confirms Withholding Tax Terms
May 28, 2026
China BlueChemical has declared a final ordinary dividend of RMB 0.112 per share for the financial year ended 31 December 2025, with shareholders’ approval obtained on 28 May 2026. For Hong Kong shareholders, the dividend will be paid in Hon...
China BlueChemical Changes Venue for 28 May 2026 Shareholder Meetings
May 21, 2026
China BlueChemical has announced a change in the venue for its annual general meeting, as well as its H shareholders’ and domestic shareholders’ class meetings, all scheduled for 28 May 2026. The meetings will now be held at the 1st Fl...
China BlueChemical Executive Director Resigns Amid Board Transition
May 11, 2026
China BlueChemical has announced the resignation of executive director Ms. He Qunhui, effective 11 May 2026, citing other work arrangements as the reason for her departure. Ms. He stated she has no disagreements with the board and no additional ma...
China BlueChemical Clarifies Board and Committee Structure
May 11, 2026
China BlueChemical has announced the current composition of its Board of Directors, detailing a mix of executive, non-executive and independent non-executive directors led by executive director and chairman Hou Xiaofeng. The disclosure also clarif...
China BlueChemical Denies Participation in Indian Urea Tender Amid Market Rumours
Apr 28, 2026
China BlueChemical issued a voluntary clarification after market rumours suggested it had secured a winning bid in a recent global urea tender in India. The board stated that the company did not participate in the tender, whether directly or via a...
China BlueChemical Seeks Mandate for Up to 10% H-Share Buyback
Apr 13, 2026
China BlueChemical has called a domestic shareholders’ class meeting for 28 May 2026 in Haikou to vote on granting its board a general mandate to repurchase up to 10% of its overseas listed H shares. The plan would allow the board to set spe...
China BlueChemical Sets 2025 Final Dividend and Clarifies Tax Treatment for H‑Shareholders
Apr 13, 2026
China BlueChemical has declared a final ordinary dividend of RMB 0.112 per share for the financial year ended 31 December 2025, with shareholder approval scheduled for 28 May 2026 and payment due on 30 June 2026. The dividend timetable sets the ex...
China BlueChemical Sets 2026 AGM to Approve Results, Dividends and New Share Mandate
Apr 13, 2026
China BlueChemical has convened its annual general meeting for 28 May 2026 in Haikou, where shareholders will review the board report, audited financial statements for 2025, and a proposed profit distribution including final dividends. They will a...
China BlueChemical Seeks Mandate for Up to 10% H-Share Buyback
Apr 13, 2026
China BlueChemical has called an H shareholders’ class meeting in Haikou on 28 May 2026, immediately after its 2025 annual general meeting, to seek approval for a special resolution granting the board a general mandate to repurchase up to 10...
China BlueChemical Posts Stable 2025 Revenue as Profit Margins Narrow
Mar 18, 2026
China BlueChemical reported 2025 revenue of RMB12.03 billion, with gross profit of RMB1.57 billion and profit attributable to owners of RMB974 million. Basic earnings per share reached RMB0.21, and the board proposed a final dividend of RMB0.112 p...
China BlueChemical Proposes Final 2025 Dividend and Clarifies Tax Treatment for H Shareholders
Mar 18, 2026
China BlueChemical Ltd. has announced a proposed final ordinary cash dividend of RMB 0.112 per share for the financial year ended 31 December 2025, with the dividend payable in Hong Kong dollars on 30 June 2026, subject to shareholder approval. Ke...
China BlueChemical Sets March 2026 Board Meeting to Approve 2025 Results and Final Dividend
Mar 3, 2026
China BlueChemical Ltd. has scheduled a board meeting to be held over 17–18 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider a...
China BlueChemical Hands Fudao Chemical Operations to CNOOC Unit Under De Minimis Connected Deal
Mar 1, 2026
China BlueChemical has moved to deepen operational integration within the CNOOC group by entrusting CNOOC Oil Petrochemicals with the daily production and operations management of its affiliate Fudao Chemical from March 2026 to February 2029. The...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.